Is Genotype Testing Really Cost-Effective for Primary Resistance in Brazil?

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):e54-6. doi: 10.1097/QAI.0000000000000875.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • Drug Resistance, Viral*
  • Female
  • Genotyping Techniques / economics*
  • Genotyping Techniques / methods*
  • HIV / drug effects*
  • HIV Infections / drug therapy*
  • HIV Infections / virology*
  • Humans
  • Male

Substances

  • Anti-Retroviral Agents